Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

Blood (2021) 138 (Supplement 1): 1477.

https://doi.org/10.1182/blood-2021-145483

Published: 2021

Journal Articles

Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan

Yoshitaka Miyakawa, MD, PhD, Shinya Katsutani, MD, PhD, Takahiro Yano, MD, PhD, Shosaku Nomura, MD, PhD, Kaichi Nishiwaki, MD, Yoshiaki Tomiyama, MD, PhD, Masaaki Higashihara, MD, PhD, Yukari Shirasugi, MD, PhD, Masakatsu Nishikawa, MD, PhD, Katsutoshi Ozaki, MD, PhD, Kayoko Kikuchi, Takayuki Abe, PhD, Yuji Sato, MD, PhD, Yuzuru Kanakura, Kingo Fujimura, MD, PhD, Yasuo Ikeda, MD, PhD, Shinichiro Okamoto, MD, PhD

Blood (2013) 122 (21): 3554.

https://doi.org/10.1182/blood.V122.21.3554.3554

Published: 2013

Journal Articles

Stat3 Activation in Donor CD4 T-Cells Is Critical for Acute Gvhd

Katsutoshi Ozaki, Haruko Matsu, MD, PhD, Keiko Hatanaka, Akiko Meguro, MD, PhD, Iekuni Oh, MD, PhD, Raine Tatara, MD, PhD, Takahiro Suzuki, Masaki Mori, M.D, Ph.D, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, M.D, Ph.D

Blood (2011) 118 (21): 1906.

https://doi.org/10.1182/blood.V118.21.1906.1906

Published: 2011

Journal Articles

Clinical Features of De Novo CD25-Positive Diffuse Large B-Cell Lymphoma

Shin-ichiro Fujiwara, Kazuo Muroi, Yuji Hirata, Kazuya Sato, Tomohiro Matsuyama, Ken Ohmine, Takahiro Suzuki, Katsutoshi Ozaki, Masaki Mori, M.D, Ph.D, Tadashi Nagai, MD, PhD, Keiya Ozawa, M.D, Ph.D

Blood (2011) 118 (21): 2666.

https://doi.org/10.1182/blood.V118.21.2666.2666

Published: 2011

Journal Articles

Lack of IL-21 Signal Attenuates Graft-Versus-Leukemia Effect In the Absence of CD8 T-Cells.

Katsutoshi Ozaki, MD, PhD, Akiko Meguro, Keiko Hatanaka, Iekuni Oh, Haruko Matsu, Raine Tatara, Kazuya Sato, MD, Warren J Leonard, Keiya Ozawa, MD, PhD

Blood (2010) 116 (21): 3739.

https://doi.org/10.1182/blood.V116.21.3739.3739

Published: 2010

Journal Articles

“Incidental Carcinomas” Detected by PET/CT Scans In the Patients with Malignant Lymphoma: A Single-Center Experience with 363 Patients

Kazuya Sato, MD, PhD, Katsutoshi Ozaki, MD, PhD, Tomohiro Matsuyama, MD, Ken Ohmine, MD, PhD, Takahiro Suzuki, MD, PhD, Masaki Mori, MD, PhD, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD

Blood (2010) 116 (21): 4132.

https://doi.org/10.1182/blood.V116.21.4132.4132

Published: 2010

Journal Articles

Six Month Treatment of Low Dose Eltrombopag Is Efficacious in Japanese Patients with Refractory Chronic Immune Thrombocytopenic Purpura (ITP).

Yoshiaki Tomiyama, MD, Yoshitaka Miyakawa, MD, PhD, Shinichiro Okamoto, MD, PhD, Shinya Katsutani, MD, Akiro Kimura, MD, Yasushi Okoshi, MD, PhD, Haruhiko Ninomiya, MD, PhD, Hiroshi Kosugi, MD, PhD, Shosaku Nomura, MD, Katsutoshi Ozaki, MD, Yasuo Ikeda, MD, Nobuyuki Koh, Koichi Katsura, MD, PhD, Yuzuru Kanakura, MD, PhD

Blood (2009) 114 (22): 1324.

https://doi.org/10.1182/blood.V114.22.1324.1324

Published: 2009

Journal Articles

Mesenchymal Stem Cells Inhibit Th17 Differentiation through PGE2 Production.

Raine Tatara, Katsutoshi Ozaki, Lekuni Oh, Keiko Hatanaka, Akiko Meguro, Haruko Matsu, Kazuya Sato, Tadashi Nagai, Kazuo Muroi, Keiya Ozawa

Blood (2009) 114 (22): 3633.

https://doi.org/10.1182/blood.V114.22.3633.3633

Published: 2009

Journal Articles

Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.

Kaoru Hatano, Jiro Kikuchi, Masaaki Takatoku, Rumi Shimizu, Taeko Wada, Masuzu Ueda, Masaharu Nobuyoshi, Iekuni Oh, Kazuya Sato, Takahiro Suzuki, Katsutoshi Ozaki, Masaki Mori, Tadashi Nagai, Kazuo Muroi, Yasuhiko Kano, Yusuke Furukawa, Keiya Ozawa

Blood (2008) 112 (11): 1634.

https://doi.org/10.1182/blood.V112.11.1634.1634

Published: 2008

Journal Articles

Blocking of IL-21 Signal Attenuates Graft-Versus-Host Disease but Not Graft-Versus-Leukemia Effect in a Mouse Model

Akiko Meguro, Katsutoshi Ozaki, Iekuni Oh, Haruko Matsu, Keiko Hatanaka, Raine Tatara, Warren J Leonard, Kazuya Sato, Keiya Ozawa

Blood (2008) 112 (11): 1248.

https://doi.org/10.1182/blood.V112.11.1248.1248

Published: 2008

Journal Articles

Notch Signaling Pathway in Hematopoietic Stem Cells Is Activated through Interactive Communication with Mesenchymal Stem Cells.

Yuji Kikuchi, Akihiro Kume, Masashi Urabe, Hiroaki Mizukami, Takahiro Suzuki, Katsutoshi Ozaki, Tadashi Nagai, Keiya Ozawa

Blood (2007) 110 (11): 1408.

https://doi.org/10.1182/blood.V110.11.1408.1408

Published: 2007

Journal Articles

Mesenchymal Stem Cells Produce Nitric Oxide, a Key Molecule for T Cell Suppression, upon Interaction with Activated T Cells.

Kazuya Sato, MD, Katsutoshi Ozaki, MD, PhD, Iekuni Oh, MD, PhD, Akiko Meguro, MD, Reine Tatara, MD, Keiko Hatanaka, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD

Blood (2006) 108 (11): 2556.

https://doi.org/10.1182/blood.V108.11.2556.2556

Published: 2006

Journal Articles

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

Kazuya Sato, Katsutoshi Ozaki, Iekuni Oh, Akiko Meguro, Keiko Hatanaka, Tadashi Nagai, Kazuo Muroi, Keiya Ozawa

Blood (2006) 109 (1): 228–234.

https://doi.org/10.1182/blood-2006-02-002246

Published: 2006

Includes: Supplemental data

Journal Articles

Mesenchymal Stem Cells (MSCs) Suppress T Cell Proliferation by a Novel NO-stat5 Dependent Mechanism.

Kazuya Sato, MD, Katsutoshi Ozaki, MD, PhD, Iekuni Oh, MD, Keiko Hatanaka, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD

Blood (2005) 106 (11): 1393.

https://doi.org/10.1182/blood.V106.11.1393.1393

Published: 2005

Journal Articles

CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk

Atsushi Oda, Hans D. Ochs, Laurence A. Lasky, Susan Spencer, Katsutoshi Ozaki, Mitsuhiro Fujihara, Makoto Handa, Kenji Ikebuchi, Hisami Ikeda

Blood (2001) 97 (9): 2633–2639.

https://doi.org/10.1182/blood.V97.9.2633

Published: 2001

Journal Articles

Thrombopoietin Induces Association of Crkl With STAT5 But Not STAT3 in Human Platelets

Katsutoshi Ozaki, Atsushi Oda, Hiroshi Wakao, Jennifer Rhodes, Brian J. Druker, Akaru Ishida, Masatoshi Wakui, Shinichiro Okamoto, Kayo Morita, Makoto Handa, Norio Komatsu, Hideya Ohashi, Atsushi Miyajima, Yasuo Ikeda

Blood (1998) 92 (12): 4652–4662.

https://doi.org/10.1182/blood.V92.12.4652

Published: 1998

Journal Articles

Collagen Induces Tyrosine Phosphorylation of Wiskott-Aldrich Syndrome Protein in Human Platelets

Atsushi Oda, Hans D. Ochs, Brian J. Druker, Katsutoshi Ozaki, Chiaki Watanabe, Makoto Handa, Yoshitaka Miyakawa, Yasuo Ikeda

Blood (1998) 92 (6): 1852–1858.

https://doi.org/10.1182/blood.V92.6.1852

Published: 1998

Journal Articles

Erythropoietin Induces Tyrosine Phosphorylation of Jak2, STAT5A, and STAT5B in Primary Cultured Human Erythroid Precursors

Atsushi Oda, Kenichi Sawada, Brian J. Druker, Katsutoshi Ozaki, Hina Takano, Kazuki Koizumi, Yoshikazu Fukada, Makoto Handa, Takao Koike, Yasuo Ikeda

Blood (1998) 92 (2): 443–451.

https://doi.org/10.1182/blood.V92.2.443

Published: 1998

Journal Articles

Thrombopoietin and Thrombin Induce Tyrosine Phosphorylation of Vav in Human Blood Platelets

Yoshitaka Miyakawa, Atsushi Oda, Brian J. Druker, Katsutoshi Ozaki, Makoto Handa, Hideya Ohashi, Yasuo Ikeda

Blood (1997) 89 (8): 2789–2798.

https://doi.org/10.1182/blood.V89.8.2789

Published: 1997

NARROW

Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan

Stat3 Activation in Donor CD4 T-Cells Is Critical for Acute Gvhd

Clinical Features of De Novo CD25-Positive Diffuse Large B-Cell Lymphoma

Lack of IL-21 Signal Attenuates Graft-Versus-Leukemia Effect In the Absence of CD8 T-Cells.

“Incidental Carcinomas” Detected by PET/CT Scans In the Patients with Malignant Lymphoma: A Single-Center Experience with 363 Patients

Six Month Treatment of Low Dose Eltrombopag Is Efficacious in Japanese Patients with Refractory Chronic Immune Thrombocytopenic Purpura (ITP).

Mesenchymal Stem Cells Inhibit Th17 Differentiation through PGE2 Production.

Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.

Blocking of IL-21 Signal Attenuates Graft-Versus-Host Disease but Not Graft-Versus-Leukemia Effect in a Mouse Model

Notch Signaling Pathway in Hematopoietic Stem Cells Is Activated through Interactive Communication with Mesenchymal Stem Cells.

Mesenchymal Stem Cells Produce Nitric Oxide, a Key Molecule for T Cell Suppression, upon Interaction with Activated T Cells.

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

Mesenchymal Stem Cells (MSCs) Suppress T Cell Proliferation by a Novel NO-stat5 Dependent Mechanism.

CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk

Thrombopoietin Induces Association of Crkl With STAT5 But Not STAT3 in Human Platelets

Collagen Induces Tyrosine Phosphorylation of Wiskott-Aldrich Syndrome Protein in Human Platelets

Erythropoietin Induces Tyrosine Phosphorylation of Jak2, STAT5A, and STAT5B in Primary Cultured Human Erythroid Precursors

Thrombopoietin and Thrombin Induce Tyrosine Phosphorylation of Vav in Human Blood Platelets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only